Scott Haufe insider trades: Medovex (MDVX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Scott reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 19, 2017 | MDVX | ↓ Sell | 70,000 | $1.19 | $83K | Direct | Sep 21, 2017 (2d) |
| Apr 18, 2017 | MDVX | ↑ Buy | 50,000 | $1.25 | $63K | Direct | Apr 18, 2017 (0d) |
| Mar 28, 2017 | MDVX | ↑ Buy | 250,612 | $1.29 | $323K | Direct | Mar 30, 2017 (2d) |
| Nov 23, 2015 | MDVX | ↑ Buy | 5,000 | $1.35 | $7K | Direct | Nov 25, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Scott Haufe's insider trades
Scott Haufe is a director at Medovex (MDVX). Since Nov 23, 2015, Scott has reported 3 open-market purchases worth $393K and 1 sale worth $83K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.